In addition, NO also acts as a mediator during tissue inflammation in IBD, as production of NO was found to be increased in IBD patients, and therefore found to be associated with the enhanced activity of iNOS in the inflamed mucosa of the gut (51). This evidence concerns the gene NOS2 and inflammatory bowel disease.